Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement C3aR depletion reverses HIF-1α-induced metabolic impairment and enhances microglial response to Aβ pathology. | J Clin Invest | 2023 | 37317973 | PubTator, text mining | PubMed |
| Inflammatory Mesenchymal Stem Cells Express Abundant Membrane-Bound and Soluble Forms of C-Type Lectin-like CD248. | Int J Mol Sci | 2023 | 37298499 | PubTator, text mining | PubMed |
| Deciphering the Role of the Anaphylatoxin C3a: A Key Function in Modulating the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37296948 | PubTator, text mining | PubMed |
| Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer. | Cell Death Dis | 2023 | 37291119 | PubTator, text mining | PubMed |
| Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes. | Cell Rep Med | 2023 | 37290439 | PubTator, text mining | PubMed |
| Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism. | Nat Commun | 2023 | 37286573 | PubTator, text mining | PubMed |
| Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia. | Front Immunol | 2023 | 37266435 | PubTator, text mining | PubMed |
| Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis. | Front Immunol | 2023 | 37261353 | PubTator, text mining | PubMed |
| Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development. | Pharmaceuticals (Basel) | 2023 | 37259459 | PubTator, text mining | PubMed |
| Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor-modulating factors. | Blood Adv | 2023 | 37257194 | PubTator, text mining | PubMed |
| Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. | Pathol Res Pract | 2023 | 37244049 | PubTator, text mining | PubMed |
| Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease. | Int J Mol Sci | 2023 | 37240105 | PubTator, text mining | PubMed |
| Identification of Key Inflammation-related Genes as Potential Diagnostic Biomarkers of Sepsis. | Altern Ther Health Med | 2023 | 37235492 | PubTator, text mining | PubMed |
| Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis. | J Immunol Res | 2023 | 37228444 | PubTator, text mining | PubMed |
| Complement: Functions, location and implications. | Immunology | 2023 | 37222083 | PubTator, text mining | PubMed |
| Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease. | Open Access Rheumatol | 2023 | 37214353 | PubTator, text mining | PubMed |
| Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear. | Front Immunol | 2023 | 37207197 | PubTator, text mining | PubMed |
| A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement. | Bone Marrow Transplant | 2023 | 37202544 | PubTator, text mining | PubMed |
| Post-COVID mRNA-vaccine IgG4 shift: worrisome? | mSphere | 2023 | 37191589 | PubTator, text mining | PubMed |
| Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches. | Cells | 2023 | 37190096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=17